These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25193267)

  • 1. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
    Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
    AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel.
    Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S
    Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.
    Zhang P; Lu J; Huang Y; Zhao W; Zhang Y; Zhang X; Li J; Venkataramanan R; Gao X; Li S
    AAPS J; 2014 Jan; 16(1):114-24. PubMed ID: 24281690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
    Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S
    Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel.
    Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Li S
    Mol Pharm; 2013 Aug; 10(8):2880-90. PubMed ID: 23768151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
    Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
    Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
    Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
    Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
    Zhang X; Huang Y; Zhao W; Chen Y; Zhang P; Li J; Venkataramanan R; Li S
    Mol Pharm; 2014 Aug; 11(8):2807-14. PubMed ID: 24987803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance.
    Lu J; Zhao W; Liu H; Marquez R; Huang Y; Zhang Y; Li J; Xie W; Venkataramanan R; Xu L; Li S
    J Control Release; 2014 Dec; 196():272-86. PubMed ID: 25456831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
    Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
    Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
    Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N
    Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
    Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
    Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
    Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
    Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.